The ways of the USFDA are inscrutable and put in peril the fate of Pharma stocks. One stock saw its fortunes surging after a clean-chit. However, the fortunes will now plunge because the clean-chit is withdrawn. Traders are caught in the whipsaw and are crying foul at their mega losses
Edelweiss’ technical stock recommen dations have heavily outperformed in 2017-18 with 41% Alpha. Their stock picks for 2018-19 are expected to deliver 53% gain
Basant Maheshwari’s PMS Fund has clocked in an impressive performance despite the gloomy state of the stock market. He has also revealed top secrets of his investment strategy. It is certain that if we follow the same strategy, we can also rake in hefty gains for our own portfolios
Equitymaster has painted a rosy picture of Akash Prakash’s stock pick and highlighted all of its virtues. The stock appears to have all the attributes of a multibagger and we must grab it before anyone else
Madhusudan Kela, the visionary stock picker, has opined that the time is now ripe to aggressively buy Pharma stocks because they are available at cheap valuations and are bottoming out
Kenneth Andrade of Old Bridge Capital has sent the wake up call that we have to take advantage of the crash in stock prices to load up on high-quality stocks at cheap valuations. He has also explained the investment rationale of his latest stock picks
Four eminent stock wizards have toiled hard to cherry-pick eighteen high quality stocks for us. The stocks are fail-safe and have the potential to shower multibagger gains upon us
Sharekhan’s recommendations for Diwali 2016 have yielded a magnificent gain of 42%. They have assured that the recommendations for 2017 will yield similar mega returns
While novice investors turn a deaf ear to Rakesh Jhunjhunwala’s gospels, Porinju Veliyath pays close attention to them. He has taken a cue from the Badshah and recommended buy of stocks with global competitive advantages
Rakesh Jhunjhunwala’s latest stock is one where Porinju Veliyath has already pocketed multibagger gains. It is explicit that more gains are due from the stock and so we have to make a beeline for it
Recent Comments